---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-010668"
form_type: "8-K"
ticker: "BTCY"
cik: "0001630113"
company_name: "BIOTRICITY INC."
filed_at: "2023-04-03T23:59:59+00:00"
generated_at: "2026-06-17T07:02:04.807005+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Biotricity shareholders approve 2023 equity plans, reverse split up to 1:10, and $10M convertible note issuance

## Summary
- Approved 2023 Equity Incentive Plan reserving 5M shares plus any unissued from 2016 plan (15.7M votes for).
- Authorized reverse stock split within 1:2 to 1:10 ratio, with Board discretion to implement within one year (27.5M for).
- Approved potential issuance of up to $10M common stock upon conversion of convertible notes (17.3M for, 629.8K against).
- Ratified SRCO Professional Corporation as independent auditor for FY ending March 31, 2023 (28.7M for).
- Directors elected: Waqaas Al-Siddiq, David A. Rosa, Ronald McClurg, Chester White.

## SEC filing metadata
- accession: 0001493152-23-010668
- form_type: 8-K
- ticker: BTCY
- cik: 0001630113
- company_name: BIOTRICITY INC.
- filed_at: 2023-04-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630113/000149315223010668/0001493152-23-010668-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630113/000149315223010668/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-010668
- JSON: https://secwatch.observer/filing/0001493152-23-010668.json
- Plain text: https://secwatch.observer/filing/0001493152-23-010668.txt

## Key facts
- Shareholder Votes
  BIOTRICITY INC. shareholders approved Advisory vote on the frequency of future advisory votes on executive compensation.
  - Proposal: say on pay frequency
  - Outcome: passed
  source text: Year Abstain 5,211,232 189,147 12,566,007 120,883 7. The Company’s stockholders approved and ratified the Company’s 2023 Employee Stock Purchase Plan.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315223010668/0001493152-23-010668-index.htm
- Shareholder Votes
  BIOTRICITY INC. shareholders approved Approval and ratification of the Company’s 2023 Employee Stock Purchase Plan.
  - Proposal: equity plan
  - Outcome: passed
  source text: The Company’s stockholders approved and ratified the Company’s 2023 Employee Stock Purchase Plan
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315223010668/0001493152-23-010668-index.htm
- Shareholder Votes
  BIOTRICITY INC. shareholders approved Approval of potential issuance of securities of up to $10,000,000 of common stock upon conversion of convertible promissory notes.
  - Outcome: passed
  source text: The Company’s stockholders approved the potential issuance of securities
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315223010668/0001493152-23-010668-index.htm
- Shareholder Votes
  BIOTRICITY INC. shareholders approved Approval to grant discretionary authority to the Board to effect a reverse stock split at a ratio between 1-for-2 and 1-for-10.
  - Proposal: reverse split
  - Outcome: passed
  source text: The Company’s stockholders approved the vote to grant discretionary authority
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315223010668/0001493152-23-010668-index.htm
- Shareholder Votes
  BIOTRICITY INC. shareholders approved Ratification of the appointment of SRCO Professional Corporation as the independent registered public accounting firm for the period ending March 31, 2023.
  - Proposal: auditor ratification
  - Outcome: passed
  source text: The Company’s stockholders ratified the appointment of SRCO Professional Corporation
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315223010668/0001493152-23-010668-index.htm
- Shareholder Votes
  BIOTRICITY INC. shareholders approved Advisory non-binding vote to approve the compensation of the named executive officers.
  - Proposal: say on pay
  - Outcome: passed
  source text: The Company’s stockholder held an advisory non-binding vote to approve the compensation
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315223010668/0001493152-23-010668-index.htm
- Shareholder Votes
  BIOTRICITY INC. shareholders approved Election of six directors.
  - Proposal: director election
  - Outcome: passed
  source text: Director Nominee Votes For Votes Against Votes Withheld Waqaas Al-Siddiq 17,934,880 10,746,690 152,389 David A. Rosa 16,201,827 10,746,690 1,885,442 Ronald McClurg 18,028,722 10,746,690 58,547 Chester White 17,628,790 10,746,690 458,479
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315223010668/0001493152-23-010668-index.htm
- Shareholder Votes
  BIOTRICITY INC. shareholders approved Approval and ratification of the Company’s 2023 Equity Incentive Plan, including the reservation of 5,000,000 shares of common stock.
  - Proposal: equity plan
  - Outcome: passed
  source text: The Company’s stockholders approved and ratified the Company’s 2023 Equity Incentive Plan
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315223010668/0001493152-23-010668-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.